Everolimus-induced posterior reversible encephalopathy syndrome and bilateral optic neuropathy after kidney transplantation

Transplantation. 2014 Dec 27;98(12):e102-4. doi: 10.1097/TP.0000000000000551.

Authors

Sara Touhami¹, Nadia Arzouk, Adil Darugar, Emmanuel Heron, Frederic Clarençon, Bahram Bodaghi, Phuc LeHoang, Benoit Barrou, Valerie Touitou

Affiliation

¹ 1 Ophthalmology Department DHU View Maintain, Hôpital Pitié Salpêtrière Paris, France 2 Urology, Nephrology and Transplantation Department Hôpital Pitié Salpêtrière Paris, France 3 Internal Medicine Department CHNO des Quinze-vingts, Charenton Paris, France 4 Neuroradiology Department Hôpital Pitié Salpêtrière Paris, France 5 Université Pierre et Marie Curie (UMPC) Faculté de Médecine Paris, France.

PMID: 25955341
DOI: 10.1097/TP.0000000000000551

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Everolimus
Female
Glomerulonephritis, IGA / surgery
Humans
Immunosuppressive Agents / adverse effects*
Kidney Transplantation*
Middle Aged
Optic Nerve Diseases / chemically induced*
Posterior Leukoencephalopathy Syndrome / chemically induced*
Postoperative Complications
Sirolimus / adverse effects
Sirolimus / analogs & derivatives*
Sirolimus / therapeutic use
Vision, Ocular / drug effects

Substances

Immunosuppressive Agents
Everolimus
Sirolimus